Videos

IHME's Dr. Alize Ferrari shares the latest findings from GBD 2021, showing how the COVID-19 pandemic changed trends in global health from the last 30 years.

Measures to slow the spread of COVID-19 also worked to prevent other lower respiratory infections, like influenza and RSV. IHME Associate Professor Dr. Hmwe Hmwe Kyu shares new findings from the Global Burden of Disease study.

The COVID-19 pandemic had a profound impact on health trends in 2020 and 2021, becoming the second-leading cause of death around the world. Dr. Mohsen Naghavi shares these findings and more from the latest Global Burden of Disease study.

By 2050, more than three-quarters of countries will not have fertility rates high enough to sustain population size over time. Dr. Austin Schumacher shares the latest Global Burden of Disease findings on past and future trends in global fertility.

Despite concerted efforts, global milestones to end TB by 2020 were not met. Dr. Hmwe Hmwe Kyu shares the latest data on tuberculosis eradication.

In 2021, nervous system disorders like Alzheimer's disease, stroke, and epilepsy affected 40% of the population. Researcher Jaimie Steinmetz shares the latest findings from IHME's GBD study.

IHME Director Dr. Christopher Murray discusses what makes the Global Burden of Disease Study (GBD) unique as the most comprehensive effort to measure health trends and why GBD remains more relevant than ever.

Congratulations to Ibrahim Abubakar for winning the 2023 Roux Prize! His work on The Lancet Nigeria Commission directly led to Nigeria’s passing a new law mandating basic health insurance and the creation of a fund for vulnerable populations that covers 83 million underprivileged people.

Mary Dempsey was working for the National Tuberculosis Association when she wrote an article in which the key health metric Years of Life Lost was first conceptualized. Kris Larsen interviews IHME director, Christopher Murray about the woman and the metric.

IHME faculty member Theo Vos presents on the research agenda for long COVID as part of the EU-US Conference on Long COVID.

Antimicrobial resistance (AMR) is a global health threat and growing problem.

IHME Director Dr. Christopher Murray explains a new star-rating system used to determine the strength of evidence behind certain health risks.

Mukti Bosco received the 2022 Roux Prize for her work bringing primary health care and preventive care to rural communities in India.

Learn how to use the Burden of Proof tool to explore the strength of evidence between health risks and outcomes, indicating the likelihood of certain behaviors have an impact on health. 

IHME director Christopher J. L. Murray presents as part of the Berkeley Graduate Lectures series.